Although mutation of GBA1 increases the incidence of cancer, including liver cancer, and one recent study showed that inhibition of GBA1 leads to reversal of gastric cancer chemoresistance [28], the role of GBA1 in cancer progression remains largely unknown. This evidence concerns the gene GBA1 and gastric cancer.